AGEN
Price
$4.13
Change
+$0.70 (+20.41%)
Updated
Jun 2 closing price
Capitalization
113.23M
SNPX
Price
$2.66
Change
-$0.01 (-0.37%)
Updated
Jun 3, 10:30 AM (EDT)
Capitalization
3.72M
Interact to see
Advertisement

AGEN vs SNPX

Header iconAGEN vs SNPX Comparison
Open Charts AGEN vs SNPXBanner chart's image
Agenus
Price$4.13
Change+$0.70 (+20.41%)
Volume$1.68M
Capitalization113.23M
Synaptogenix
Price$2.66
Change-$0.01 (-0.37%)
VolumeN/A
Capitalization3.72M
AGEN vs SNPX Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. SNPX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and SNPX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (AGEN: $4.13 vs. SNPX: $2.67)
Brand notoriety: AGEN and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 219% vs. SNPX: 539%
Market capitalization -- AGEN: $113.23M vs. SNPX: $3.72M
AGEN [@Biotechnology] is valued at $113.23M. SNPX’s [@Biotechnology] market capitalization is $3.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNPX is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish.

  • AGEN’s TA Score: 4 bullish, 5 bearish.

Price Growth

AGEN (@Biotechnology) experienced а +8.12% price change this week, while SNPX (@Biotechnology) price change was +18.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +2.04%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($113M) has a higher market cap than SNPX($3.72M). SNPX has higher P/E ratio than AGEN: SNPX (2.75) vs AGEN (0.14). AGEN YTD gains are higher at: 50.730 vs. SNPX (-22.911). SNPX has higher annual earnings (EBITDA): -6.76M vs. AGEN (-77.64M). AGEN has more cash in the bank: 44.8M vs. SNPX (22.1M). AGEN has higher revenues than SNPX: AGEN (160M) vs SNPX (0).
AGENSNPXAGEN / SNPX
Capitalization113M3.72M3,039%
EBITDA-77.64M-6.76M1,149%
Gain YTD50.730-22.911-221%
P/E Ratio0.142.755%
Revenue160M0-
Total Cash44.8M22.1M203%
Total Debt78.4MN/A-
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UURAF1.070.14
+14.57%
Ucore Rare Metals, Inc.
BDORY4.200.05
+1.20%
Banco Do Brasil SA
BYDDF49.680.13
+0.27%
BYD Co., Ltd.
RNLSY9.99-0.27
-2.68%
Renault SA
WRDLY2.68-0.24
-8.28%
Worldline SA

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
+20.41%
SNPX - AGEN
91%
Closely correlated
+6.36%
ALLR - AGEN
87%
Closely correlated
+3.23%
NRXP - AGEN
83%
Closely correlated
+1.52%
PALI - AGEN
81%
Closely correlated
+2.43%
AXON - AGEN
42%
Loosely correlated
+1.09%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+6.36%
NCNA - SNPX
92%
Closely correlated
+7.65%
RNAC - SNPX
91%
Closely correlated
+4.39%
AGEN - SNPX
91%
Closely correlated
+20.41%
ALLR - SNPX
87%
Closely correlated
+3.23%
NRXP - SNPX
84%
Closely correlated
+1.52%
More